Neuropeptide Y is stored in sympathetic nerve terminals throughout the heart and has direct and indirect effects on cardiac function. Although neuropeptide Y has been shown to be released upon intense (16-30 Hz) cardiac sympathetic stimulation, we sought to determine whether effective quantities of neuropeptide Y were released from cardiac sympathetic neurons under more natural conditions. We recorded arterial pressure and cardiac cycle length in 29 anesthetized dogs. We assessed neuropeptide Y release by measuring the attenuation of vagally induced increases in cardiac cycle length (10 seconds every 2 minutes) after trams of sympathetic stimulation. We examined the effect of constant-frequency sympathetic stimulation (frequencies of 2, 5,10, and 15 Hz, applied for train durations of 1,3, and 5 minutes) on vagally induced chronotropk responses. We also determined the effect of varying the pattern of sympathetic stimulation. Both the magnitude and duration of the inhibition of the vagal effects on cardiac cycle length were augmented significantly by increases in the frequency or duration of sympathetic stimulation. In contrast, the inhibition of the vagally induced chronotropic responses was not significantly affected by changes in the pattern of sympathetic stimulation. We also characterized the role of adrenergic receptors. Phentolamine significantly increased the sympathetically mediated inhibition of the vagal effects on cardiac cycle length, but propranolol had no effect. We concluded that neuropeptide Y release from cardiac sympathetic neurons 1) depends on the frequency and duration, but not on the pattern, of sympathetic stimulation; 2) is evoked even at physiological frequencies (2-5 Hz) of sympathetic activity; and 3) is enhanced by a-adrenergic-receptor blockade, but is unaffected by 0-adrenergicreceptor blockade. (Circulation Research 1989;64:882-889)
T he autonomic nervous system modulates cardiac chronotropic, inotropic, and dromotropic processes. 1 -2 Our current understanding of the autonomic control of the heart is based mainly on the effects of norepinephrine and acetylcholine, neurotransmitters that are released from the cardiac sympathetic and parasympathetic nerves, respectively.
-
2 Recently, however, it has been shown that autonomic neurons, including those to the heart, contain various neuropeptides in addition to the "classical" neurotransmitters. 3 -7 These neuropeptides may act as neurotransmitters or neuromodulators.
The most abundant neuropeptide found in cardiac autonomic nerves is neuropeptide Y, a 36-amino acid peptide that coexists with norepinephrine in cardiac sympathetic nerve terminals. Neuropeptide Y is released together with norepinephrine upon direct stimulation of sympathetic fibers. 11 -14 In the anesthetized dog, Potter 15 demonstrated that the vagal actions on heart rate were attenuated after brief periods of intense sympathetic stimulation. Potter attributed the inhibition of the vagal effects on heart rate to the release of neuropeptide Y from sympathetic nerve endings, because 1) the inhibition remained in the presence of adrenergic-receptor blockade, and 2) the inhibition was mimicked by exogenous neuropeptide Y.i5,i6 Additional evidence suggests that neuropeptide Y attenuates cardiac vagal actions by inhibiting the release of acetylcholine from postganglionic parasympathetic neurons. 1617 Lundberg et al 17 showed that in the isolated guinea pig atrium, after /3-adrenergic-receptor blockade exogenous neu-ropeptide Y attenuated the negative chronotropic and inotropic responses evoked by field stimulation. Furthermore, in this preparation exogenous neuropeptide Y did not significantly modify the inhibitory responses elicited by exogenous acetylcholine. Similarly, Potter 16 showed in the anesthetized dog that increases in cardiac cycle length evoked by bethanechol were not affected by exogenous neuropeptide Y or by sympathetic stimulation, whereas vagally induced increases in cycle length were inhibited by either sympathetic stimulation or exogenous neuropeptide Y. Hence, the inhibitory effect of sympathetic stimulation (presumably mediated by neuropeptide Y) appears to occur prejunctionally, on the vagal nerve endings, rather than postjunctionally, on the cardiac cell membrane.
Although norepinephrine and neuropeptide Y are released concomitantly upon sympathetic activation,"-' 418 substantial evidence suggests that much higher stimulation frequencies are required to release detectable quantities of neuropeptide Y than of norepinephrine. 131518 The pattern of stimulation also substantially affects the release of neuropeptide Y from splenic nerve fibers in the pig 13 and calf. 18 The location of neuropeptide Y in sympathetic nerve endings throughout the heart suggests that neuropeptide Y can modulate all aspects of cardiac function. Therefore, we sought to determine in more detail the stimulation conditions that release neuropeptide Y from cardiac sympathetic neurons. In our experiments we monitored the sympathetically mediated inhibition of the vagal effects on cycle length as an indirect measure of neuropeptide Y release. We examined the effects of the level (i.e., frequency and duration) of sympathetic stimulation as well as the effect of the pattern of sympathetic stimulation on the inhibition of vagally induced chronotropic responses. We also determined the role of a-and /3-adrenergic receptors in the sympathetically mediated inhibition of vagally induced chronotropic responses.
Materials and Methods

Preparation
Experiments were carried out on 29 mongrel dogs (14-27 kg) that were premedicated with morphine sulfate (2 mg/kg i.m.) and anesthetized with o-chloralose (75 mg/kg i.v.). A femoral artery was cannulated for arterial pressure measurement (Statham model P23AC, Gould, Cleveland, Ohio). The ipsilateral femoral vein was cannulated for the administration of drugs and the maintenance of fluid balance. The cervical vagi were isolated, doubly ligated, and sectioned to interrupt descending parasympathetic outflow to the heart. Bipolar hook electrodes were inserted into the cardiac end of each vagus, and the wires were connected in parallel to a stimulator (Grass Instrument, Quincy, Massachusetts).
The trachea was intubated and intermittent positive pressure ventilation was begun. The chest was opened transversely at the fourth intercostal space. The right and left stellate ganglia were isolated, doubly ligated, and sectioned to eliminate descending cardiac sympathetic outflow. 19 The ansae subclaviae were placed over bipolar shielded indium electrodes (Harvard Apparatus, South Natick, Massachusetts), and the electrode wires were connected in parallel to a Grass stimulator. The pericardium was opened, and a bipolar electrode catheter was inserted into the right atrial appendage to record an atrial electrogram. Arterial blood pressure, right atrial electrogram, and A-A interval were recorded continuously (model ES 1000, Gould). The A-A interval (cardiac cycle length) was determined from the atrial electrogram by an analog computer (model 580, Electronic Associates, Inc, West Long Beach, New Jersey).
Stimulation Conditions
The vagi were stimulated supramaximally (6-8 V, 1-msec pulse width) for 10 seconds every 2 minutes. The vagal stimulation frequency was adjusted to elicit approximately a 100% increase in cardiac cycle length under control conditions. The vagal stimulation frequencies ranged from 1.5 to 6 Hz in individual animals.
Two modes of supramaximal stimulation (8 V, 1-msec pulse width), either constant or patterned stimulation, were applied to the ansae subclaviae. The constant stimulation was delivered to the ansae subclaviae at frequencies of 2, 5, 10, and 15 Hz for train durations of 1, 3, and 5 minutes. The order of application of the combinations of frequency and duration was randomized according to a Latinsquare design. Specific protocols involving constant frequency stimulation are described in the results.
For the second stimulation mode, patterned stimulation, we programmed a microprocessor (model ET-3400A, Heath Co, Benton Harbor, Michigan) to generate continuous (100% duty cycle) and intermittent (50% or 25% duty cycle) sympathetic stimulation patterns. The stimulation patterns were delivered to the sympathetic nerves at mean frequencies of 2, 5, and 10 Hz, each for a train duration of 3 minutes. The protocol used to deliver continuous and intermittent stimulation patterns at a mean frequency of 5 Hz with a 1-second subperiod is shown in Figure 1 . During continuous stimulation, five pulses were delivered over 100% of each 1-second subperiod. For a 50% duty cycle, the five pulses were delivered during half of each 1-second subperiod, and no pulses were delivered during the remaining half of the subperiod. Similarly, for a 25% duty cycle, the five pulses were delivered in 0.25 second, and no pulses were delivered in the remaining 0.75 second of the subperiod.
We also programmed the microprocessor to generate patterned sympathetic stimulation delivered at mean frequencies of 2,5, and 10 Hz, but based on a 10-second subperiod. Thus, we applied 20-Hz stimulation for 1, 2.5, or 5 seconds but delivered no pulses during the remaining portion of the 10-second subperiod. For example, when we applied 20-Hz stimulation for 2.5 seconds and no pulses during the remaining 7.5 seconds, the mean frequency of pulse delivery was 5 Hz (i.e., 50 pulses/10 sec=5 Hz). We compared the effects of the intermittent stimulation with the effects of continuous sympathetic stimulation delivered at 2, 5, and 10 Hz. Although the patterns of stimulation differed (i.e., continuous versus intermittent stimulation), the total number of pulses delivered to the sympathetic nerves at a given mean frequency remained constant for equal durations of stimulation. All stimulations were applied for a train duration of 3 minutes.
Drugs
Propranolol (1 mg/kg i.v.) was administered to block /3-adrenergic receptors. We considered the blockade of /3-adrenergic receptors to be adequate if the cycle length did not change in response to sympathetic stimulation. Phentolamine (2 mg/kg i.v.) was given to block a-adrenergic receptors. To assess whether the a-adrenergic-receptor blockade was adequate, we monitored the pressor response to phenylephrine (2-4 fig/kg i.v.) before and after the administration of phentolamine. In the absence of phentolamine, the phenylephrine induced an increase of 43.6±4.7 mm Hg in mean arterial pressure (n=5).
After phentolamine, the phenylephrine elicited no appreciable increase in mean arterial pressure.
Data Analysis
We determined statistical significance by analysis of variance. We considered a significance level of p-^5% to be statistically significant. We fitted curves to the data by nonlinear regression analysis (STAT-GRAPHICS, Statistical Graphics Corp, Rockville, Maryland) and integrated the curves to determine their areas. Data are presented as mean±SEM. Figure 2 shows a representative example of the cardiac chronotropic responses to our stimulation protocol. Before sympathetic stimulation, the vagi were stimulated for 10 seconds every 2 minutes at a frequency that increased cardiac cycle length by about 100%. After two control vagal stimulations in this example, a train of stimuli (10 Hz for 5 minutes) was delivered to the ansae subclaviae. Cardiac cycle length decreased from 420 to 270 msec during ansal stimulation.
Results
Representative Experiments
After sympathetic stimulation was discontinued, the vagi were again stimulated for 10 seconds every 2 minutes until the vagally induced chronotropic response returned to control. As shown in Figure 2 , the vagally induced cycle-length responses after sympathetic stimulation were initially much smaller than those evoked before sympathetic stimulation. For example, before sympathetic stimulation, vagal stimulation increased cycle length by 460 msec (i.e., cycle length increased from 420 to 880 msec). In contrast, 4 minutes after cessation of sympathetic stimulation the identical vagal stimulation increased cycle length by only 170 msec (i.e., cycle length increased from 410 to 580 msec). Thus, the vagally induced response 4 minutes after sympathetic stimulation was inhibited by 63%. Note that in Figure 2 the chronotropic response to vagal stimulation required about 38 minutes to return to control. We used the stimulation protocol illustrated in Figure 2 to determine the effect of various levels and patterns of sympathetic stimulation on the vagally induced chronotropic responses. Figure 3 shows a representative example of the recovery of vagally induced cardiac cycle-length responses (expressed as percent of control) after the termination of 5-minute trains of sympathetic stimulation delivered at frequencies of 5, 10, and 15 Hz. Note that as the frequency of sympathetic stimulation was incremented from 5 to 15 Hz, the initial inhibition (at t=2 minutes) of the vagal effects on cycle length increased and the time course of recovery was more prolonged. For example, after sympathetic stimulation at 5 Hz, the initial chronotropic response to vagal stimulation was inhibited by 53%, whereas after sympathetic stimulation at 15 Hz, the initial chronotropic response to vagal stimulation was inhibited by 86%. The corresponding times for the chronotropic responses to return to their control values were about 20 and 60 minutes, respectively.
Composite Data
Effect of level of sympathetic stimulation. We determined the effect of the frequency and duration of sympathetic stimulation on the vagally induced chronotropic responses by stimulating the ansae subclaviae at 5, 10, and 15 Hz and applying each frequency for train durations of 1, 3, and 5 minutes. For each of the nine sympathetic stimulation combinations we quantitated the initial inhibition, which we defined as the first vagally induced chronotropic response (i.e., at t=2 minutes in Figure 3 ) after the termination of sympathetic stimulation. The initial inhibition was calculated as lOOCRc-RJ/R,., where Rî s the control vagally induced cycle-length response (before sympathetic stimulation) and R, is the first experimental response (after sympathetic stimulation). The initial inhibition data from five animals are summarized in the top panel of Figure 4 . Analysis of variance showed that changes in the frequency (p=0.005) and duration (p=0.002) of the sympathetic stimulation train significantly affected the initial inhibition of the chronotropic response to vagal stimulation.
We also quantitated the summated inhibition, which we defined as the area between the response curve and the horizontal line that represents 100% of the control response (e.g., as in Figure 3 ). This area represents the effect of the train of sympathetic stimulation on the chronotropic responses to vagal stimulation summated over the full duration of the response. The summated inhibition data are summarized in the bottom panel of Figure 4 . Analysis of variance revealed that changes in the frequency (p=0.01) and duration (p=0.02) of sympathetic stimulation significantly affected the summated inhibition.
We determined the relation between the initial and summated inhibition of the vagal effects on cardiac cycle length by plotting each summated inhibition versus its corresponding initial inhibition. Figure 5 shows a plot of these data, which were represented by an equation that we determined by nonlinear regression analysis as Figure 4 represent mean±SEM of these data.
100
FIGURE 5. Relation between summated inhibition and initial inhibition of vagal effects on cardiac cycle length evoked by sympathetic stimulation. Data points represent initial and summated inhibition obtained after 5-, 10-, and 15-Hz sympathetic stimulation delivered using train durations of I, 3, and 5 minutes in five animals. Data shown in
The square of the curvilinear correlation coefficient (R 2 ) for the data shown in Figure 5 is 0.87. Thus, 87% of the relation between the initial and summated inhibition is accounted for by the above regression equation; R 2 serves as a criterion of the goodness of fit.
Effect of pattern of sympathetic stimulation. We followed the stimulation protocol used in the experiment illustrated in Figure 2 to compare the effects of continuous and intermittent sympathetic stimulation patterns on the vagally induced chronotropic responses. We initially tested the effects of three different duty cycles (25%, 50%, and 100%) and three different frequencies (2, 5, and 10 Hz) of sympathetic stimulation, each delivered for a train duration of 3 minutes. The various combinations of duty cycles and stimulation frequency were applied in a random sequence. For each 3-minute train of sympathetic stimulation, we calculated the initial and summated inhibition of the vagally induced chronotropic responses. The data (n=5) are summarized in Figure 6 . The mean frequency of sympathetic stimulation significantly affected the initial inhibition (p<0.001, top panel) and summated inhibition (p<0.001, bottom panel). Thus, as the mean frequency of sympathetic stimulation was incremented, both the initial inhibition and the summated inhibition were significantly augmented. In contrast, at any given mean frequency, the pattern of sympathetic stimulation (i.e., 25%, 50%, or 100% duty cycle) did not significantly affect the initial inhibition (p=0.9) or the summated inhibition (p=0.9).
To determine whether various stimulation patterns might evoke different effects if longer subperiods were used, we next examined sympathetic Stimulation Duty Cycle (%)
FIGURE 6. Effect of pattern and mean frequency of sympathetic stimulation on initial (top panel) and summated (bottom panel) inhibition of vagally induced chronotropic responses. The 100%, 50%, and 25% duty cycles were based on a 1-second subperiod. Bars represent mean±SEM (n=5).
stimulation patterns delivered with a 10-second subperiod. During each 10-second subperiod we applied a 20-Hz train of stimulation for 1, 2.5, or 5 seconds, but delivered no pulses during the remaining portion of the subperiod; these patterns corresponded to mean frequencies of 2,5, and 10 Hz. We compared the effect of the intermittent stimulation with the effect of continuous sympathetic stimulation delivered at frequencies of 2, 5, and 10 Hz. The initial and summated inhibition data are summarized in Figure 7 (n=5). The mean frequency of sympathetic stimulation significantly affected the initial inhibition (p=0.001, top panel) and summated inhibition (p=0.001, bottom panel). At any given mean frequency (i.e., 2, 5, or 10 Hz), however, the initial inhibition after the termination of continuous (bars labeled C) stimulation was not significantly different (p=0.6) from the initial inhibition after the termination of intermittent (bars labeled I) sympathetic stimulation. Similarly, at any given mean frequency, the summated inhibition was not significantly (p=0.8) affected by the pattern (continuous versus intermittent) of sympathetic stimulation. The data in Figures 6 and 7 show that the mean frequency of sympathetic stimulation significantly influences the inhibition of the vagal effects on cardiac cycle length but that the pattern of sympathetic stimulation does not, regardless of the frequency of stimulation. 
FIGURE 7. Effect of continuous (C) and intermittent (I) sympathetic stimulation at three mean frequencies on initial (top panel) and summated (bottom panel) inhibition of vagally induced chronotropic responses. Intermittent stimulations were based on a 10-second subperiod. Bars represent mean±SEM (n=5).
Role of adrenergic-receptor blockade. The release of norepinephrine from sympathetic nerve terminals is altered by a-and ^-adrenergic-receptor blockade. l214 Because neuropeptide Y is also released from sympathetic nerve terminals, 111318 we sought to determine whether a-or ^-adrenergic-receptor antagonists modulated the release of neuropeptide Y. In addition, we examined whether the norepinephrine-induced decrease in cardiac cycle length during sympathetic stimulation (e.g., Figure 2 ) influenced the persistent inhibition of the vagal effects on cardiac cycle length.
Animals were assigned randomly to a control (n=5), propranolol (n=4), or phentolamine (n=5) group. For each group the experiments were subdivided into two observation periods. During the first observation period, six trains of stimulation (2 and 5 Hz, each for train durations of 1, 3, and 5 minutes) were delivered in random sequence to the ansae subclaviae. We followed the protocol used in the experiment shown in Figure 2 to determine the effects of each combination of sympathetic stimulation frequency and train duration on the chronotropic responses to vagal stimulation. At the end of observation period 1, we administered saline, propranolol, or phentolamine to the animals in the control, propranolol, or phentolamine groups, respectively. During observation period 2, we repeated the six trains of sympathetic stimulation after a new randomization. In the control group, comparison of the responses obtained during periods 1 and 2 provided information about the changes in cardiac responses over time. In the propranolol and phentolamine groups, period 1 served as an internal control for the effects of propranolol and phentolamine, respectively.
The initial inhibition data are summarized in Figure 8 . In the control group and in the group that received propranolol ( Figures 8A and 8B and Figures 8C and 8D, respectively) , the initial inhibitions obtained during period 1 were not significantly different (p=0.7 and p=03, respectively) from the initial inhibitions obtained during period 2. In the group that received phentolamine ( Figures 8E and  8F) , however, the initial inhibitions were significantly augmented (p<0.001) after phentolamine (period 2) at sympathetic stimulation frequencies of either 2 or 5 Hz.
Qualitatively similar results were obtained for the summated inhibition in each of the three experimen- tal groups (data not shown). In the control and propranolol groups, the summated inhibitions in period 1 were not significantly different from the summated inhibitions in period 2 (p=0.9 and/?=0.6, respectively). In the phentolamine group, however, the summated inhibitions were significantly augmented after phentolamine (p<0.001). Therefore, a-adrenergic-receptor blockade significantly increased the magnitude and duration of the sympathetically induced inhibition of the vagal effects on cardiac cycle length, whereas neither /3-adrenergicreceptor blockade nor the passage of time affected the inhibition appreciably.
Discussion
Our results showed that the inhibition of the vagal effects on cardiac cycle length that is evoked by sympathetic stimulation 1) depends on the frequency and duration of sympathetic stimulation, 2) occurs even at physiological frequencies (2-5 Hz) of sympathetic stimulation, 3) is not significantly affected by substantial changes in the pattern of sympathetic stimulation, 4) is significantly enhanced by a-adrenergic-receptor blockade, and 5) is unaffected by £-adrenergic-receptor blockade. The longlasting inhibition of the vagally induced chronotropic responses that occurs after sympathetic stimulation is probably ascribable to the release of neuropeptide Y from the sympathetic nerve endings. Because neuropeptide Y antagonists are not available to date, however, we cannot rule out the possibility that another mechanism may be at least partly responsible for the observed results.
In the present experiments we used a protocol similar to that described by Potter 15 to indirectly measure the release of neuropeptide Y from cardiac sympathetic neurons in the anesthetized dog. Potter showed that the vagal actions on cardiac cycle length were attenuated after short periods of intense sympathetic stimulation (i.e., at frequencies of [16] [17] [18] [19] [20] . Our experiments confirm Potter's results, because we also found that high-frequency sympathetic stimulation (e.g., 10 and 15 Hz) persistently inhibited the vagal effects on cardiac cycle length (Figures 2-4) . Moreover, our data extend Potter's previous studies by demonstrating that 1) both the magnitude (initial inhibition) and duration (summated inhibition) of the inhibition of vagally induced chronotropic responses are significantly affected by the frequency and duration of sympathetic stimulation ( Figures 3 and 4) , and 2) even low frequencies of sympathetic stimulation (2-5 Hz) can inhibit the vagal effects on cardiac cycle length ( Figures 3, 4 , 6-8) . This latter observation is important because functional effects of neuropeptide Y have not previously been reported in response to low levels of sympathetic stimulation. The release of neuropeptide Y at naturally occurring frequencies of sympathetic activity (e.g., 5 Hz) suggests that neuropeptide Y may act to regulate cardiac function under physiological conditions. In support of this conclusion, Potter" demonstrated that cardiac vagal effectiveness was inhibited after a reflexly mediated increase of sympathetic activity.
Lundberg et al 13 showed that in the isolated pig spleen, the neuropeptide Y release was much greater when the splenic nerve was stimulated with short bursts of 20-Hz stimulation than when the nerve was stimulated with the same number of pulses, but at a steady low frequency (2 Hz) of stimulation. Similarly, Allen et al 18 demonstrated in the conscious calf that the mean plasma neuropeptide Y concentration was significantly greater after stimulation of the splenic nerves with 40-Hz bursts of stimuli than when the same number of stimuli was delivered with continuous low-frequency (4-Hz) stimulation. These studies showed that the pattern of stimulation influenced the release of neuropeptide Y from the sympathetic neurons of the spleen of pigs and calves. In our experiments, changing the pattern of cardiac sympathetic stimulation did not significantly alter the chronotropic response to vagal stimulation in dogs (Figures 6 and 7) . The inhibition of the vagal effects on cardiac cycle length, however, was significantly affected by the frequency and duration of sympathetic stimulation (Figures 3,  4, 6-8) . Thus, in the dog heart neuropeptide Y release is affected by the total number of impulses delivered to the sympathetic nerves, but is not very sensitive to the pattern with which those impulses are delivered, at least with the varieties of patterns that we examined in our study.
Several factors may account for the differences between our observations in the dog heart and those obtained in the spleens of pigs and calves. Lundberg et al 13 and Allen et al 18 measured directly the amount of neuropeptide Y released during splenic nerve stimulation. However, we indirectly measured neuropeptide Y release by monitoring a functional response (i.e., the neuropeptide Y-induced inhibition of vagally induced chronotropic responses). Thus, it is possible that in our preparation the quantity of neuropeptide Y release did change in response to the different patterns of cardiac sympathetic stimulation, but that the change in neuropeptide Y release did not appreciably affect the functional response. This possibility is unlikely, however, because our data demonstrate that the inhibition of the cardiac vagal effects was intensified significantly as we increased the frequency or duration of sympathetic stimulation (Figures 3, 4, 6-8 ). Therefore, if the different sympathetic stimulation patterns used in our study produced significant changes in neuropeptide Y release, those changes must have been substantially less than those evoked by the changes we induced in the duration or mean frequency of sympathetic stimulation. Alternatively, the differences in the effect of pattern of sympathetic stimulation on neuropeptide Y release in our studies and in the experiments of Lundberg et al 13 or Allen et al 18 may reflect a tissue or species variation.
Activation of the a-adrenergic receptors located on sympathetic nerve terminals inhibits the release of norepinephrine from those nerve endings, whereas blockade of a-adrenergic receptors enhances norepinephrine release. 1214 Data obtained in the pithed guinea pig and in the anesthetized pig show that the stimulation-evoked release of neuropeptide Y from sympathetic nerve endings is also enhanced after the blockade of a-adrenergic receptors."- 20 Indeed, Rudehill et al" showed that the sympathetic stimulation-evoked overflow of neuropeptide Y from the heart increased threefold after a-adrenergic-receptor blockade. Our data extended these findings by demonstrating that the inhibition of cardiac vagal effects resulting from a given frequency of sympathetic stimulation was significantly greater after a-adrenergic-receptor blockade than under control conditions ( Figure 8 ). Thus, in the heart, the effect of a-adrenergic-receptor blockade on neuropeptide Y release is functionally significant. Additionally, our results with adrenergic receptor antagonists extended the data of Potter.
l3 Although Potter demonstrated that the sympathetically mediated inhibition of the vagal actions on heart rate remained after combined a-and /3-adrenergic-receptor blockade, she did not analyze separately the effects of a-and /3-adrenergic-receptor antagonists. Our data showed that the inhibition of cardiac vagal effects evoked by sympathetic stimulation is unaffected by 0-adrenergicreceptor blockade, but is significantly enhanced by a-adrenergic-receptor blockade (Figure 8 ). Although the inhibition of the vagal effects on cycle length is nonadrenergic in origin, the inhibition is modulated by a-adrenergic-receptor blockade.
Note added in proof: After we submitted this manuscript, a relevant study by T.D. Gardner and E.K. Potter was published in the Journal of Physiology (Dependence of non-adrenergic inhibition of cardiac vagal action on peak frequency of sympathetic stimulation in the dog. J Physiol [Lond] 1988,405:115-122). In contrast to our results (Figures 6 and 7) , which show that the pattern of sympathetic stimulation did not affect the inhibition of vagally induced cycle length responses, Gardner and Potter show that the pattern of stimulation did affect the inhibition of vagal effects on cycle length. The reasons for this discrepancy are unclear.
